(NASDAQ: ANGO) Angiodynamics's forecast annual revenue growth rate of 2.75% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.99%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.8%.
Angiodynamics's revenue in 2025 is $286,498,000.On average, 3 Wall Street analysts forecast ANGO's revenue for 2025 to be $11,550,774,771, with the lowest ANGO revenue forecast at $11,538,392,264, and the highest ANGO revenue forecast at $11,569,146,203. On average, 3 Wall Street analysts forecast ANGO's revenue for 2026 to be $12,297,650,362, with the lowest ANGO revenue forecast at $12,159,945,555, and the highest ANGO revenue forecast at $12,499,857,510.
In 2027, ANGO is forecast to generate $12,810,229,498 in revenue, with the lowest revenue forecast at $12,810,229,498 and the highest revenue forecast at $12,810,229,498.